Works matching IS 0167594X AND DT 2019 AND VI 144 AND IP 3


Results: 19
    1
    2
    3
    4

    Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 553, doi. 10.1007/s11060-019-03257-1
    By:
    • Correa, Denise D.;
    • Braun, Erica;
    • Kryza-Lacombe, Maria;
    • Ho, Ka-Wai;
    • Reiner, Anne S.;
    • Panageas, Katherine S.;
    • Yahalom, Joachim;
    • Sauter, Craig S.;
    • Abrey, Lauren E.;
    • DeAngelis, Lisa M.;
    • Omuro, Antonio
    Publication type:
    Article
    5

    Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 591, doi. 10.1007/s11060-019-03261-5
    By:
    • Kinslow, Connor J.;
    • Garton, Andrew L.A.;
    • Rae, Ali I.;
    • Marcus, Logan P.;
    • Adams, Christopher M.;
    • McKhann, Guy M.;
    • Sisti, Michael B.;
    • Connolly, E. Sander;
    • Bruce, Jeffrey N.;
    • Neugut, Alfred I.;
    • Sonabend, Adam M.;
    • Canoll, Peter;
    • Cheng, Simon K.;
    • Wang, Tony J. C.
    Publication type:
    Article
    6

    CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 583, doi. 10.1007/s11060-019-03260-6
    By:
    • Figura, Nicholas B.;
    • Potluri, Thrisha K.;
    • Mohammadi, Homan;
    • Oliver, Daniel E.;
    • Arrington, John A.;
    • Robinson, Timothy J.;
    • Etame, Arnold B.;
    • Tran, Nam D.;
    • Liu, James K.;
    • Soliman, Hatem;
    • Forsyth, Peter A.;
    • Sahebjam, Solmaz;
    • Yu, H. Michael;
    • Han, Hyo S.;
    • Ahmed, Kamran A.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 501, doi. 10.1007/s11060-019-03246-4
    By:
    • Kebir, Sied;
    • Schaub, Christina;
    • Junold, Nina;
    • Hattingen, Elke;
    • Schäfer, Niklas;
    • Steinbach, Joachim P.;
    • Weyerbrock, Astrid;
    • Hau, Peter;
    • Goldbrunner, Roland;
    • Galldiks, Norbert;
    • Weller, Johannes;
    • Mack, Frederic;
    • Tzaridis, Theophilos;
    • Bähr, Oliver;
    • Seidel, Clemens;
    • Schlegel, Uwe;
    • Schmidt-Graf, Friederike;
    • Rohde, Veit;
    • Borchers, Christian;
    • Tabatabai, Ghazaleh
    Publication type:
    Article